This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Traystman, R. J. Articles by Hademenos, G. Search for Related Content PubMed PubMed Citation Articles by Traystman, R. J. Articles by Hademenos, G. Related Collections Health policy and outcome research Cerebrovascular disease/stroke AHA Statements and Guidelines

(Stroke. 1999;30:1147.)
© 1999 American Heart Association, Inc.

Special Report

Increased Funding for Stroke Research

Richard J. Traystman, PhD George Hademenos, PhD

From the Departments of Anesthesiology/Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Md (R.J.T.), and the American Heart Association, Dallas, Tex (G.H.).

Key Words: American Heart Association • editorial

	Introduction

 
It is an exciting time for stroke research. Over the last couple of years with the use of tPA, and now at the most recent International Stroke and Cerebral Circulation Conference meeting, the announcement of 2 promising new thrombolytic agents (Ancrod and Pro-urokinase) for acute stroke treatment, it is an exciting time indeed. Neuroprotective agents are still being investigated, and while an effective neuroprotective agent has not yet been identified in humans, almost assuredly one will come to light soon. The American Heart Association/American Stroke Association (AHA/ASA) is making significant efforts to provide dollars for stroke research for both clinical and basic science areas. The AHA/ASA for 1997–98 provided some $6 million for stroke-specific research, with a projection for the year 2001 of $11.3 million. Another $33.7 million was provided for research that was related in some way to stroke. In addition, there is a very exciting new commitment of $7.5 million from the Henrietta B. and Frederick H. Bugher Foundation and $3.7 million from the AHA for a new research program targeted to stroke. The AHA-Bugher Foundation Awards for the Investigation of Stroke are intended to stimulate the development of better stroke preventive measures, better stroke interventions, and a greater understanding of the cerebrovasculature. These awards will be made for the study of any aspect of brain vascular function related to stroke, and these investigations will include both clinical and basic science research in these areas. The Bugher Award will provide $100,000/year for a total 4-year maximum of $400 . . . [Full Text of this Article]

This article has been cited by other articles:

				Y. Dai and J. H. Zhang Manipulation of chloride flux affects histamine-induced contraction in rabbit basilar artery Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1427 - H1436. [Abstract] [Full Text] [PDF]